Last Updated on July 16, 2026 by Dr. Bhagat
JOURNAL METRICS·Updated June 2026
Nature Reviews Bioengineering Impact Factor 2025 is 28.8 (Q1, Biomedical Engineering, SCIE). Debuting in 2023, this Springer Nature journal has quickly emerged as a leading voice in bioengineering with a CiteScore of 32.5.
The field of bioengineering sits at one of the most dynamic intersections in modern science—where biology meets engineering principles to solve medical, environmental, and industrial challenges. Nature Reviews Bioengineering, launched by Springer Nature in 2023, arrived precisely when the discipline needed a dedicated, high-impact review platform. With a 2025 Impact Factor of 28.8, it has immediately claimed a top-tier position in the Biomedical Engineering category.
What makes this journal’s early performance particularly impressive is its timing. Unlike disciplines with centuries of publishing tradition, bioengineering as a distinct field is still defining its intellectual boundaries. By publishing reviews on organ-on-chip technology, biomaterials for regenerative medicine, synthetic biology toolkits, and neural engineering interfaces, the journal is actively shaping those boundaries rather than merely reflecting them.
DETAILED METRICSComplete Indicator Overview
| Indicator | Value | Source / Notes |
|---|---|---|
| Impact Factor 2025 | 28.8 | Clarivate JCR; Q1 Biomedical Eng. |
| CiteScore 2025 | 32.5 | Scopus, 4-year window |
| SJR | 8.2 | Scopus prestige-weighted |
| h-index | 12 | Rapid early accumulation |
| SNIP | 4.52 | Scopus normalized |
| ISSN | 2731-6092 | Electronic |
| Publisher | Springer Nature | London, UK |
| Established | 2023 | 2 years of publication |
| Indexing | SCIE, Scopus | Full coverage |
The h-index of 12, while modest compared to century-old journals, is extraordinary for a publication only two years old. It indicates that a significant portion of early articles have already achieved double-digit citations—a strong predictor of continued growth.
SCOPE AND COVERAGEWhat the Journal Publishes
Nature Reviews Bioengineering publishes commissioned review articles covering tissue engineering, biomaterials, drug delivery systems, medical devices, synthetic biology, computational bioengineering, and bioprocessing. The editorial team prioritizes reviews that translate fundamental engineering principles into clinically or industrially relevant applications.
A distinguishing feature is the journal’s emphasis on “engineering design principles” in biological contexts. Rather than treating biology as a black box to be manipulated, reviews often explore how engineering frameworks—control theory, transport phenomena, systems design—can be formally applied to living systems.
FREQUENTLY ASKED QUESTIONSCommon Queries Answered
What is the Impact Factor of Nature Reviews Bioengineering?
The 2025 Impact Factor is 28.8, based on Clarivate Journal Citation Reports.
When was Nature Reviews Bioengineering launched?
The journal launched in 2023, making it one of the newest titles in the Nature Reviews portfolio.
Is this a Q1 journal?
Yes, it ranks in Q1 of the Biomedical Engineering category in both JCR and Scopus.
What is the ISSN of Nature Reviews Bioengineering?
The ISSN is 2731-6092 (electronic).
Does the journal accept unsolicited manuscripts?
Most content is commissioned by the editorial team. However, prospective authors can submit proposals for review topics through the journal’s website.
How does it compare to Nature Biomedical Engineering?
Nature Biomedical Engineering publishes original research, while Nature Reviews Bioengineering publishes commissioned reviews only. Both are Q1 journals but serve different scholarly needs.
Key Takeaways
- Nature Reviews Bioengineering holds a 2025 Impact Factor of 28.8, Q1 in Biomedical Engineering.
- Launched in 2023, it achieved an exceptional first Impact Factor, reflecting strong field demand.
- CiteScore of 32.5 and SJR of 8.2 demonstrate genuine scholarly prestige beyond raw citation counts.
- ISSN 2731-6092; published by Springer Nature; indexed in SCIE and Scopus.
- Content focuses on tissue engineering, biomaterials, medical devices, and synthetic biology applications.
